Access Now: AORN COVID-19 Clinical Support

Home >  News >  March, 2018

Study Finds Psychosis Drug Amisulpride Reduces Nausea and Vomiting

Small doses of amisulpride, a drug used to manage psychosis, may prevent PONV when given with standard anti-nausea treatment, say researchers.

Published: March 16, 2018

Nausea FEELING QUEASY Researchers believe a common anti-psychosis drug could have prevented this patient's post-operative nausea.

Patients given a small intraoperative dose of an antipsychotic medication used to treat schizophrenia along with a common anti-nausea drug had significantly less post-operative nausea and vomiting (PONV) than patients given a placebo, reports a study in the American Society of Anesthesiologists' Online First edition of Anesthesiology.

Amisulpride, sold under the brand name Solian, is commonly used in Europe to manage psychosis and is currently under review by the U.S. Food and Drug Administration. The drug works by blocking dopamine signaling without inducing the irregular heart rhythms and drug-induced movement disorders that occurred when similar drugs were used to control nausea and vomiting in the past.

Researchers in Europe and the United States conducted a double-blind placebo-controlled study where patients with high-risk of PONV were given an anti-nausea drug (usually ondansetron or dexamethasone) along with 5mg of intravenously delivered amisulpride or a placebo. More than half (58%) of patients given amisulpride had no vomiting or need for fast-acting medication to prevent vomiting 24 hours after surgery. All PONV occurrences were lower in the amisulpride group. Only 14% had vomiting compared to 20% in the placebo, 50% had any nausea compared to 58% in the placebo, 37% had significant nausea compared to 48% in the placebo and 41% required fast-acting medication to stop vomiting compared to 49% in the placebo.

"This could enable improved control of PONV and allow for earlier mobilization and discharge of surgical patients," says lead author Peter Kranke, MD, in the ASA press release. "Patients with multiple risk factors for PONV require a multimodal approach for its prevention, including using a combination of anti-nausea drugs with different mechanisms of action, since it cannot be predicted which pathways will be active in a patient."

JoEllen McBride, PhD

Also in the News...

APIC Survey Reveals Depth of PPE Shortages
COVID-19 Call to Action
Virtual OR Excellence Still Going Strong
Lessons Learned During the Pandemic
Handle Workplace Legal Issues Like a Pro
The Secret to Safer Surgery
Remember Why You Work in Surgery

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Surgery During the Surge

Outpatient facilities remain ready to care for patients, even with COVID-19 infection rates on the rise.

Product News

Great Ideas for your OR

ASCA Calls for Continued Access to Care During COVID-19

The surgery center association lobbies Congress for support of patients who need elective surgery and the providers who can deliver it.